
Friends Speciality Medicine Private Limited
Pharmaceutical company manufacturing and trading medical products such as injections, tablets, and capsules.
Pharmaceutical company manufacturing and trading medical products such as injections, tablets, and capsules.
Friends Speciality Medicine Private Limited (FSMPL) is a Private Limited Indian Non-Government Company incorporated in India on 13 November 2018 (Six years and three months 19 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 Cr and a paid-up capital of Rs 4.25 Cr.
The company currently has active open charges totaling ₹7.30 Cr. The company has closed loans amounting to ₹3.04 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ankush Sethi, Aarav Rawal, Raj Rawal, and One other member serve as directors at the Company.
Delhi, India
+91-XXXXXXXXXX
-
U74999DL2018PTC341744
341744
Private Limited Indian Non-Government Company
13 Nov 2018
30 Sep 2023
31 Mar 2023
Unlisted
Roc Delhi
Friends Speciality Medicine Private Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Cardiac Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nutraceuticals & Dietary Supplements, Fitness Supplements, Surgical & ICU Equipments, Nebulizer Machine & Parts, Brain & Nervous System Drugs, Immunomodulator Drugs.
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ankush Sethi ![]() | Additional Director | 01-Aug-2024 | Current |
Aarav Rawal ![]() | Additional Director | 01-Aug-2024 | Current |
Raj Rawal ![]() | Director | 13-Nov-2018 | Current |
Praveen Sethi ![]() | Director | 13-Nov-2018 | Current |
Friends Speciality Medicine Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.81% increase. The company also saw a slight improvement in profitability, with a 2.74% increase in profit. The company's net worth Soared by an impressive increase of 51.75%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
In 2023, Friends Speciality Medicine had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Ankush Sethi and Aarav Rawal are mutual person
Praveen Sethi is a mutual person
₹7.30 Cr
₹3.04 Cr
Date | Lender | Amount | Status |
---|---|---|---|
30 Mar 2020 | Others | ₹7.30 Cr | Open |
08 Mar 2022 | Others | ₹1.40 Cr | Satisfied |
08 Mar 2022 | Others | ₹1.64 Cr | Satisfied |
Friends Speciality Medicine has a workforce of 35 employees as of Apr 24, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Friends Speciality Medicine, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Friends Speciality Medicine's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ankush Sethi was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2024 & has been associated with this company since 7 months .
Aarav Rawal was appointed as a Additional Director was appointed as a Additional Director on 01 Aug 2024 & has been associated with this company since 7 months .
Friends Speciality Medicine Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Friends Speciality Medicine Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
A charge registered on 08 Mar 2022 via Charge ID 100545543 with Others was fully satisfied on 14 Nov 2022.
A charge registered on 08 Mar 2022 via Charge ID 100545540 with Others was fully satisfied on 30 Sep 2022.
Friends Speciality Medicine Private Limited was incorporated on 13 Nov 2018.
The authorized share capital of Friends Speciality Medicine Private Limited is ₹ 8.00 Cr and paid-up capital is ₹ 4.25 Cr.
Currently 4 directors are associated with Friends Speciality Medicine Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Friends Speciality Medicine Private Limited is Office No. 3 Ground Floor Upper Csc Motia Khan, Paharganj India, New Delhi, 110055.
The corporate identification number (CIN) of Friends Speciality Medicine Private Limited is U74999DL2018PTC341744 and the company number is 341744 as per Ministry of Corporate Affairs (MCA).
According to the financial reports for the fiscal year 2023, the revenue trend for Friends Speciality Medicine Private Limited has risen by 15.81%.
As Per 2023 financial reports, 35 employees are currently employed by Friends Speciality Medicine Private Limited.
The financial reports for the fiscal year 2023 indicates that The net worth of Friends Speciality Medicine Private Limited has experienced an upsurge of 51.75%.
As per the financial statements for fiscal Year 2023, The total open charges for Friends Speciality Medicine Private Limited amount to ₹ 7.30 Cr.
The most recent Balance Sheet for Friends Speciality Medicine Private Limited was filed with the ROC on 31 Mar 2023.